247 related articles for article (PubMed ID: 30837262)
1. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells.
Xing S; Gai K; Li X; Shao P; Zeng Z; Zhao X; Zhao X; Chen X; Paradee WJ; Meyerholz DK; Peng W; Xue HH
J Exp Med; 2019 Apr; 216(4):847-866. PubMed ID: 30837262
[TBL] [Abstract][Full Text] [Related]
2. Tcf1 and Lef1 provide constant supervision to mature CD8
Shan Q; Li X; Chen X; Zeng Z; Zhu S; Gai K; Peng W; Xue HH
Nat Commun; 2021 Oct; 12(1):5863. PubMed ID: 34615872
[TBL] [Abstract][Full Text] [Related]
3. Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity.
Xing S; Li F; Zeng Z; Zhao Y; Yu S; Shan Q; Li Y; Phillips FC; Maina PK; Qi HH; Liu C; Zhu J; Pope RM; Musselman CA; Zeng C; Peng W; Xue HH
Nat Immunol; 2016 Jun; 17(6):695-703. PubMed ID: 27111144
[TBL] [Abstract][Full Text] [Related]
4. TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.
Yang BH; Wang K; Wan S; Liang Y; Yuan X; Dong Y; Cho S; Xu W; Jepsen K; Feng GS; Lu LF; Xue HH; Fu W
Cell Rep; 2019 Jun; 27(12):3629-3645.e6. PubMed ID: 31216480
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
[TBL] [Abstract][Full Text] [Related]
6. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells.
Berga-Bolaños R; Zhu WS; Steinke FC; Xue HH; Sen JM
Mol Immunol; 2015 Dec; 68(2 Pt B):484-9. PubMed ID: 26490636
[TBL] [Abstract][Full Text] [Related]
7. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
[TBL] [Abstract][Full Text] [Related]
8. T
Li F; Zhao X; Zhang Y; Shao P; Ma X; Paradee WJ; Liu C; Wang J; Xue HH
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372138
[TBL] [Abstract][Full Text] [Related]
9. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.
Steinke FC; Xue HH
Immunol Res; 2014 Aug; 59(1-3):45-55. PubMed ID: 24847765
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
[TBL] [Abstract][Full Text] [Related]
12. T Cell factor 1 represses CD8+ effector T cell formation and function.
Tiemessen MM; Baert MR; Kok L; van Eggermond MC; van den Elsen PJ; Arens R; Staal FJ
J Immunol; 2014 Dec; 193(11):5480-7. PubMed ID: 25355919
[TBL] [Abstract][Full Text] [Related]
13. TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T
Kratchmarov R; Djeddi S; Dunlap G; He W; Jia X; Burk CM; Ryan T; McGill A; Allegretti JR; Kataru RP; Mehrara BJ; Taylor EM; Agarwal S; Bhattacharyya N; Bergmark RW; Maxfield AZ; Lee S; Roditi R; Dwyer DF; Boyce JA; Buchheit KM; Laidlaw TM; Shreffler WG; Rao DA; Gutierrez-Arcelus M; Brennan PJ
Nat Immunol; 2024 May; 25(5):902-915. PubMed ID: 38589618
[TBL] [Abstract][Full Text] [Related]
14. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.
Okamura RM; Sigvardsson M; Galceran J; Verbeek S; Clevers H; Grosschedl R
Immunity; 1998 Jan; 8(1):11-20. PubMed ID: 9462507
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
16. A network of high-mobility group box transcription factors programs innate interleukin-17 production.
Malhotra N; Narayan K; Cho OH; Sylvia KE; Yin C; Melichar H; Rashighi M; Lefebvre V; Harris JE; Berg LJ; Kang J;
Immunity; 2013 Apr; 38(4):681-93. PubMed ID: 23562159
[TBL] [Abstract][Full Text] [Related]
17. Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.
Kafka A; Bačić M; Tomas D; Žarković K; Bukovac A; Njirić N; Mrak G; Krsnik Ž; Pećina-Šlaus N
J Cell Mol Med; 2019 Jan; 23(1):641-655. PubMed ID: 30468298
[TBL] [Abstract][Full Text] [Related]
18. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells.
Fu W; Ergun A; Lu T; Hill JA; Haxhinasto S; Fassett MS; Gazit R; Adoro S; Glimcher L; Chan S; Kastner P; Rossi D; Collins JJ; Mathis D; Benoist C
Nat Immunol; 2012 Oct; 13(10):972-80. PubMed ID: 22961053
[TBL] [Abstract][Full Text] [Related]
19. TCF1 in T cell immunity: a broadened frontier.
Zhao X; Shan Q; Xue HH
Nat Rev Immunol; 2022 Mar; 22(3):147-157. PubMed ID: 34127847
[TBL] [Abstract][Full Text] [Related]
20. A central role for induced regulatory T cells in tolerance induction in experimental colitis.
Haribhai D; Lin W; Edwards B; Ziegelbauer J; Salzman NH; Carlson MR; Li SH; Simpson PM; Chatila TA; Williams CB
J Immunol; 2009 Mar; 182(6):3461-8. PubMed ID: 19265124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
